Albert Leutwiler
Corporate Officer/Principal bei Novation Pharmaceuticals, Inc.
Ursprung des Netzwerks ersten Grades von Albert Leutwiler
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Novation Pharmaceuticals, Inc.
 Novation Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Novation Pharmaceuticals, Inc. operates as a biotechnology research and development company. It provides modulation of intracellular messenger RNA (mRNA) to identify new small-molecule therapies to treat serious diseases. The company was founded by Dominique Cheneval and Tania Kastelic and is headquartered in Burnaby, Canada.
5
| Private Company | Medical/Nursing Services | 5 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Albert Leutwiler
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| Genetronics, Inc. | Director/Board Member | ||
| PCI BIOTECH HOLDING ASA | Biotechnology | Director/Board Member | |
Allergan Pharmaceuticals Ltd., Inc.
 Allergan Pharmaceuticals Ltd., Inc. Pharmaceuticals: MajorHealth Technology Allergan Pharmaceuticals Ltd., Inc. develops and distributes pharmaceuticals, biologics and medical devices. It imports and exports pharmaceutical products. The company is located in Irvine, CA | Pharmaceuticals: Major | President | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
Sandoz AG
 Sandoz AG Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz AG is a Swiss company that develops generic medicines and biosimilars. The company is based in Basel, Switzerland. | Pharmaceuticals: Generic | Corporate Officer/Principal Corporate Officer/Principal | |
| Karolinska Institutet | College/University | Doctorate Degree | |
| The Johns Hopkins University | College/University | Corporate Officer/Principal Doctorate Degree | |
| Simon Fraser University | College/University | Graduate Degree | |
| University of Saskatchewan | College/University | Undergraduate Degree | |
| Swiss Federal Institute of Technology | College/University | Doctorate Degree | |
| Umea Universitet | College/University | Graduate Degree | |
| Vancouver General Hospital | Director/Board Member | ||
| Novartis Pharma Germany | Corporate Officer/Principal | ||
| University of British Columbia Hospital Foundation | Director/Board Member | ||
| Pharmacia Canada, Inc. | Corporate Officer/Principal | ||
| Combio A/S | Chief Executive Officer | ||
| Waterstreet Technology Group | Corporate Officer/Principal | ||
Galecto Biotech ApS
 Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Galecto Biotech ApS provides galectin modulators for the treatment of severe diseases, including fibrosis and cancer. Its products include galectin-3 inhibitors, fibrosis and literature. The company was founded by Tariq Sethi, Hans Thalsgard Schambye, Ulf Jorgen Nilsson, and Hakon Leffler in 2011 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Chairman | |
| Accequa AB | Chief Executive Officer | ||
Aptahem AB
 Aptahem AB Pharmaceuticals: MajorHealth Technology Aptahem AB operates as a biotechnology company. The firm engages in developing drug candidates for the treatment and prevention of disease caused by blockages in blood vessels as the result of blood clots, such as deep vein thrombosis, stroke and heart failure. Its main business model is to clinically develop aptamer-based treatments for life-threatening acute conditions where coagulation and inflammation interact in the disease process. The company was founded byLuiza Jedlina, Bert Junno, Tina Persson and Johan Lindh in 2014 and is headquartered in Malmo, Sweden. | Pharmaceuticals: Major | Chairman | |
| Biomedical Development Europe | Corporate Officer/Principal | ||
| CYXONE AB | Pharmaceuticals: Major | Chief Executive Officer | |
| Celus Pharmaceuticals Ltd. | Chief Executive Officer |
Statistik
International
| Kanada | 9 |
| Schweden | 9 |
| Vereinigte Staaten | 5 |
| Schweiz | 4 |
| Dänemark | 3 |
Sektoral
| Health Technology | 9 |
| Consumer Services | 7 |
| Health Services | 2 |
| Finance | 2 |
| Commercial Services | 2 |
Operativ
| Director/Board Member | 14 |
| Corporate Officer/Principal | 11 |
| Chief Executive Officer | 5 |
| Chief Tech/Sci/R&D Officer | 4 |
| President | 3 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Albert Leutwiler
- Unternehmensverbindungen
